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Abstract
Background. The burden of diabetes mellitus (DM) is on the rise
especially in developing countries like India. Due to its chronic nature
DM tends to cause many debilitating complications and diabetic
peripheral neuropathy (DPN) is one of them. The aim of this study is
to determine the prevalence of DPN among patients attending a terti-
ary care hospital and to identify the determinants associated with it.
Design and methods. A cross sectional study was conducted in
Government Wenlock Hospital, Mangalore (India), during January-
February 2014. A total of 208 patients with >5 year duration of DM
were asked to respond to the patient history version of Michigan
Neuropathy Screening Instrument (MNSI) and examinations were
conducted after obtaining consent from them. The statistical analysis
was done in terms of descriptive statistics and association between
variables was tested using logistic regression test.
Results. The prevalence of DPN using the MNSI history version and
MNSI examination were found to be 18.3% and 32.2% respectively. The
major determinants associated with DPN were found to be male gen-
der (OR: 2.7, CI: 1.4-5.1, P=0.001), smoking (OR: 5.8, CI: 1.9-17.3,
P=0.001) and age >40 years (OR: 2.7, CI: 1.2-5.8, P=0.011). 
Conclusions. The burden of undetected DPN was found to be higher
among diabetics, with an especially higher prevalence among males,
smokers and those with long standing diabetes mellitus. Interventions
in the form of early detection through routine screening, smoking ces-
sation and regular follow up examinations would go a long way in
reducing the burden of disability among diabetics and improve their
quality of life significantly.
Background
Diabetes mellitus (DM) is a major public health problem worldwide.
According to the International Diabetes federation, 387 million people
have diabetes in the year 2014 and by the year 2035 the numbers will
rise to 592 million. The greatest number of cases of diabetes mellitus is
recorded in the age group between 40 and 59 years of age. With a nation-
al DM prevalence of 8.6% and 668,468,800 number of people with DM,
India stands second to China in relation to the burden of DM.1
Diabetes mellitus is a group of metabolic disorders which has a
common underlying feature of hyperglycaemia. Diabetes mellitus is
characterised by a long standing state of hyperglycaemia in a person.
It is a well-known fact that the average time gap between the onset of
diabetes and its detection in an individual is 4 to 7 years.2 As a result
of prolonged hyperglycaemic state along with degenerative changes
secondary to ageing, there are injurious effects to the tissues leading
to micro vascular and macro vascular complications. The macro-vascu-
lar complications include coronary artery disease, peripheral arterial
disease and stroke. The micro vascular complications include
retinopathy, diabetic nephropathy and peripheral neuropathy.3
One of the most chronic and debilitating complication of diabetes is
diabetic peripheral neuropathy (DPN). Diabetic neuropathies are a
group of nerve disorders caused by persistent high blood sugar levels. As
a consequence of damage to the nerves the patients develop the inability
to perceive important sensations like heat, cold and pain in extremities.
As a result of lack of these sensations the patient may not be aware of a
sore or an ulcer in the foot. This coupled with delayed/non healing of
ulcers due to DM, most of the patients end up losing their limbs. The
major problem with the development of DPN is that the changes are sub-
tle and happen as people get older, people tend to ignore the signs of
nerve damage, thinking it’s just part of getting older.4 Available evidence
suggests that the presence of DPN among patients with diabetes leads
to reduced quality of life, mainly attributable to the morbidity and mor-
tality associated with DPN.5-7 Hence, the problem of DPN demands the
application of concept of secondary prevention through early diagnosis
and treatment. Screening for DPN in clinical practice using a simple
objective tool is essential, as the detection of the various soft and subtle
signs of DPN at the earliest could minimize the damaging effects of this
serious but manageable micro vascular complication and in turn
improve the quality of life of such patients. 
This study was conducted with the objective to screen type 2 diabet-
ic patients for undetected DPN and also to identify the determinants of
diabetic peripheral neuropathy among type 2 diabetic patients. 
Design and MethodsStudy design
Facility based cross sectional studyStudy setting
The present study was conducted among patients with type-2 DM
Significance for public health
The findings of the current research hold importance since diabetes is one
of the leading causes of morbidity and mortality across the world. Due to its
chronic nature and effects of hyperglycaemia, diabetes tends to be associat-
ed with many comorbidities, like peripheral neuropathy, nephropathy,
retinopathy etc. The presence of diabetic peripheral neuropathy leads to a
reduced quality of life among diabetic patients due to the trauma and conse-
quent gangrenes andamputation. The concept of secondary prevention can
be applied to the prevention of diabetic peripheral neuropathy using easy to
apply screening tools and thus help in early diagnosis and treatment to
reduce the burden of this debilitating illness.
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attending out-patient departments (OPDs) of Government Wenlock
Hospital (GWH), an associate hospital of Kasturba Medical College
(KMC) Mangalore, Karnataka. The city of Mangalore is located in the
coastal region of Karnataka state, India. It is the second fastest devel-
oping city of Karnataka state, with a highly industrialized work envi-
ronment. The prevalence of DM in the coastal Karnataka is 16%.8 The
GWH is a tertiary care level district hospital, which is having a public
private partnership (PPP) with KMC, Mangalore. The GWH caters to
the residents of Mangalore city and the surrounding suburbs. The OPD
case load for every day ranges from 200 to 300 patients, among whom
60-70 patients will be with diabetes for followup care. Apart from every-
day medical OPDs, on every Wednesday diabetes clinic is conducted.
The patients with diabetes are, usually, attended by the consultant doc-
tors, junior residents and interns.Study duration 
The study was conducted over two month’s duration from 1st January
2014 to 28th February 2014.Study participants
The study included patients with type 2 DM with duration since diagno-
sis of more than five years. A sample size of 243 was calculated considering
a power of 80%, an absolute precision of 5%, and a confidence level of 95%
and a DPN prevalence rate of 19.1% among Indian diabetic patients.9 The
study participants were selected using convenient sampling. Study tool
The screening for DPN was conducted using the Michigan Neuropathy
Screening Instrument (MNSI). The MNSI is a validated tool for the
screening of DPN in both community and hospital set ups.10 The MNSI
includes two parts, the first part is related to patient’s perception of
symptoms in relation to DPN and the second part consists of a set of
examinations done to detect the presence of DPN among the patients.
The examinations include, i) vibration sensation test using a 128 Hz tun-
ing fork, ii) elicitation of muscle jerk reflex at the ankle joint and iii)
monofilament testing. The investigators were trained with regards to
proper conduct of examinations using the MNSI tool. All the examina-
tions conducted by the investigators were supervised by the post gradu-
ates of Department of Internal Medicine, KMC, Mangalore. The screen-
ing activities were conducted after obtaining a written informed consent
from the participants in a separate examination room. Scoring of Michigan Neuropathy Screening Instrumenthistory version
The first part of the MNSI questionnaire asks the participants about
the presence or absence of symptoms related to DPN. Responses are
added to obtain the total score. Responses of yes to items 1-3, 5-6, 8-9, 11-
12, 14-15 are each counted as one point. A no response on items 7 and
13 counts as 1 point. Item number 4 is a measure of impaired circulation
and item number 10 is a measure of general asthenia and is not included
in scoring. A score of ≥7 was taken as positive for the DPN.Scoring of Michigan Neuropathy Screening Instrumentexamination version
After examining the patient’s both extremities, each component is
given a score of 0 if no finding is present and a score of 1 if any abnor-
mality was detected. After summing up all the components if the overall
score was found to be ≥2.5, then it was considered to be positive for the
presence of DPN.
Apart from MNSI, we also collected information in relation to socio-
demographic aspects such as age, gender, marital status, literacy,
smoking and alcohol consumption. The information in relation to the
control of blood sugar level was collected based on the last fasting blood
sugar (FBS) levels examination conducted in last 30 days, the records
of which were written on patient’s out-patient cards. Since, it is the pol-
icy of the hospital to test for FBS once in 3 months; the information was
available for only 78 subjects.Data analysis
The collected information was entered and analysed using SPSS ver-
sion 16. The data was analysed in terms of descriptive statistics as well
as bivariate analysis (Chi-square test). We undertook both unadjusted
and adjusted logistic regression to assess the association between
socio-demographic variables (age, sex, marital status, literacy, smok-
ing, alcoholic status), clinical variables (duration of illness) and preva-
lence of DPN. The variables which were found to be significant on
bivariate analysis (viz. gender, smoking status, alcohol consumption
and age groups) were subjected for logistic regression. The fit of the
logistic model was assessed with the Hosmer and Lemeshow goodness-
of-fit test; P<0.05 was considered evidence of a statistically significant
difference between predictive and outcome variables. Odds ratios
(ORs) and corresponding 95% confidence intervals (CIs) are reported. Ethical considerations 
Prior to the start of the study approval was obtained from the
Institutional Ethics Committee of KMC, Mangalore. A written informed
consent was obtained from all the study participants. All the collected
information has been kept confidential.
Results
Among the 243 participants who were found to be eligible and
approached by the investigators, 208 patients with diabetes consented
to participate in our study. The response rate comes out to be 85.6%.
Among them 99 (47.6%) were males and 109 (52.4%) were females.
The mean age of the study participants was found to be 57.6±12.2 years
(range 33-82 years). The mean duration of diabetes mellitus in the
study population was found to be 9.8±2.8 years (range 5-40 years). The
remaining socio-demographic details of the participants have been pro-
vided in Table 1.Results based on Michigan Neuropathy ScreeningInstrument history (patient version)
Based on the scoring of MNSI patient version, the prevalence of DPN
was found out to be 18.3% (n=38). Table 2 presents the details of the
MNSI history version.
The prevalence of DPN was significantly higher among males, smok-
ers and alcoholics. The prevalence of DPN was also found to be higher
among patients who were more than 40 years old, with a fasting blood
glucose (FBG) of more than 120 g/dL, unmarried/widowed/divorced
individuals and those with duration of DM >10 years; however the
association was not statistically significant (Table 3).
On binary logistic regression, smoking, alcoholism and male gender
were found to be significant risk factors for DPN. The corresponding Odds
ratios and confidence intervals have been mentioned in detail in Table 4.
However, on multivariate logistic regression the risk factors which
were found to be associated with DPN were: male gender [OR: 2.4 (1.0-
5.6), P=0.046] and smoking [OR: 10.2 (3.1-33.9), P=0.001] (Table 4).Results based on Michigan Neuropathy ScreeningInstrument examination (signs)
The prevalence of Diabetic Peripheral Neuropathy was found to be
32.2% (n=67) among the study participants. The prevalence of DPN
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was significantly higher among males, smokers, and alcoholics,
patients who were more than 40 years old (Figure 1) and with a Fasting
Blood Glucose (FBG) of more than 120 g/dL. The prevalence of DPN was
also found to be higher among unmarried/widowed/divorced individu-
als and those with duration of DM >10 years; however the association
was not statistically significant (Table 5).
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Table 1. Profile of study participants (N=208).
Parameter                                                                        N.          %
Age (in years)
31-40                                                                                                         21           10.1
41-50                                                                                                         50           24.0
51-60                                                                                                         48           23.1
61-70                                                                                                         48           23.1
71-80                                                                                                         36           17.3
81-90                                                                                                          5             2.40
Education
Literates                                                                                                186          89.4
Illiterates                                                                                               022          10.6
Marital status
Married                                                                                                  187          89.9
Unmarried                                                                                             021          10.1
Smoking history
Smokers                                                                                                   038          18.3
Non-smokers                                                                                          170          81.7
Alcohol consumption
Alcoholics                                                                                              031          14.9
Non-alcoholics                                                                                     177          85.1
Duration since diagnosis of diabetes mellitus
Less than 10 years                                                                               144          69.2
More than10 years                                                                               064          30.8
Fasting blood glucose levels*
More than 120 mg/dL                                                                          038          48.7
Less than 120 mg/dL                                                                           040          51.3
*This information is available for only 78 subjects.
Table 2. Summary of participants responses to Michigan
Neuropathy Screening Instrument history questionnaire (n=208).
Symptom                                                                         N.          %
Numbness of legs and/or feet                                                             95           45.7
Burning pain in legs and/or feet                                                         104          50.0
Feet too sensitive to touch                                                                  55           26.4
Muscle cramps in legs and/or feet                                                    130          62.5
Prickling feelings in legs or feet?                                                      131          63.0
Feeling of hurt when the bed covers touch skin                             25           12.0
Ability to tell the hot water from the cold water?                           13            6.3
Ever had an open sore on the foot                                                     76           36.5
Doctor ever told you that you have diabetic neuropathy?             29           13.9
Feeling of weakness all over most of the time                              151          72.6
Symptoms worse at night                                                                    113          54.3
Legs hurt while walking                                                                        136          65.4
Ability to sense your feet while walking                                            37           17.8
Is the skin on your feet so dry that it cracks open?                       50           24.0
Ever had an amputation                                                                         0               0
Participants with a score of ≥7                                                           38           18.3
Table 4. Unadjusted and adjusted odds ratios (ORs) for determinants associated with diabetic peripheral neuropathy according to
Michigan Neuropathy Screening Instrument history version.
Determinant                                        Unadjusted ORs                              Adjusted ORs
                                                                                    OR (CI)                    P-value                                        OR (CI)                    P-value
Male sex                                                                                           2.7 (1.4-5.1)                           0.001                                                    2.3 (1.0-5.6)                           0.046
Smokers                                                                                          4.5 (2.6-7.6)                        <0.0001                                               10.2 (3.0-33.9)                         0.001
Alcoholics                                                                                        2.3 (1.3-4.2)                           0.007                                                    2.6 (0.7-9.7)                           0.155
Age >40 years                                                                                 1.7 (0.9-3.0)                           0.060                                                    1.8 (0.8-4.1)                           0.136
Fasting blood glucose >120 g/dL                                                2.7 (0.9-7.8)                           0.059                                                   3.0 (0.7-12.2)                          0.111
Figure 1. Age group wise trends of diabetic peripheral neuropa-
thy among study population.
Table 3. Socio-demographic factors of the study participants
associated with diabetic peripheral neuropathy according to the
Michigan Neuropathy Screening Instrument history version-
bivariate analysis (n=38).
                                                        N.                 %            P-value 
Gender                                                                                                            0.001
Males                                                            27                    27.3
Females                                                        11                    10.1
Cigarette smoking                                                                                      <0.0001
Smokers                                                       19                    50.0
Non-smokers                                               19                    11.2
Alcoholic status                                                                                             0.007
Alcoholics                                                    11                    35.5
Non-alcoholics                                            27                    15.3
Age                                                                                                                   0.043
30-39 years                                                    3                     21.4
40-49 years                                                   13                    25.5
50-59 years                                                    7                     16.3
60 years and older                                      15                    15.0
Fasting blood glucose                                                                                  0.054
More than 120 mg/dL                                  7                     17.5
Less than 120 mg/dL                                  14                    36.8
Marital status                                                                                                 0.198
Married                                                         32                    17.1
Unmarried/divorced/widowed                  6                     28.6
On binary logistic regression, smoking, alcoholism and male gender
were found to be significant risk factors for DPN. The corresponding Odds
ratios and confidence intervals have been mentioned in detail in Table 6.
To eliminate the effects of confounding bias, we undertook multi-
variate logistic regression. Based on this analysis, the risk factors
which were found to be associated with DPN were: smoking (OR: 5.9,
CI: 1.9-17.3, P=0.0001) and age more than 40 years (OR: 2.7, CI: 1.2-5.8,
P=0.011) (Table 6).
Discussion
The present study was conducted to assess the prevalence of DPN
among patients attending a tertiary care hospital. Majority of the par-
ticipants in our study (65.9%) belonged to the age group of more than
60 years. As per the existing national statistics, individuals aged above
60 years constitute 7.5% of the total population.11 A proportionately
higher number of older patients in our study can be explained by the
fact that NCDs commonly occur in old age and usually the diagnosis is
delayed due to late manifestations and detection of the disease. 
The prevalence of DPN according to the patient history version was
found out to be 18.3%. The prevalence was much lesser compared to the
one that we found on the basis of MNSI examination which was 32.2%.
Similar findings were observed in a study conducted in UAE.12 The dif-
ference in prevalence rates using two methods is an important finding
and it clearly demonstrates the limitations related to patient’s self-per-
ception of symptoms of DPN. Furthermore, it highlights the importance
of screening for DPN among the people with diabetes for early detec-
tion and treatment using screening techniques that involve examina-
tion of the patient.
The prevalence of DPN using MNSI examination in our study was
found to be 32.2%. Our findings are similar to studies conducted in
Iran, Turkey and Spain.13-16 However, the prevalence of DPN in other
studies conducted elsewhere showed a lot of variation, ranging from
13% to 75%.8,17-24 The difference in prevalence of DPN across the stud-
ies can be attributed to differences in diabetes duration, study designs,
type of study population included and different types of scales used to
assess the magnitude of DPN in different study settings. Nonetheless,
the high prevalence of DPN in our study highlights the importance of
proper foot care and adequate blood sugar control among diabetics.
After conducting multivariate logistic regression, we observed that
smoking (OR-5.9, CI: 1.9-17.3) was found to be significantly associated
with DPN. Similar findings were observed in studies conducted else-
where.21,23 However no such association was observed in a study con-
ducted in Iran. 24 The association between smoking and DPN can be
explained with the fact that smoking itself is an independent risk factor
for peripheral neuropathy; with the addition of DM the combination
appears to be synergistic. Also, age >40 years was found to be a signif-
icant risk factor (OR-2.7, CI: 1.2-5.8) associated with DPN. Similar find-
ings were observed in other studies.9,14-16,25,26 Ageing is a well-known
risk factor for many non-communicable diseases including DM. The
effects of ageing combined with deleterious effects of hyperglycaemia
can result in increased prevalence of DPN as one gets old. 
Upon multivariate analysis of the MNSI history version, we also
observed that male gender was significantly associated with the devel-
opment of DPN (OR-2.3 CI:1.0-5.6). Similar results were obtained in
various other studies as well.24,27,28 However, studies conducted else-
where did not observe a similar association.16,19,20,26
The limitations of our study include the following: since, this is a
facility based study which covers only that part of the diabetic popula-
tion who approached for the assistance of clinicians in hospitals for fol-
low up and management of their condition. Hence the conclusions
deduced from this study cannot be generalized to the general popula-
tion. The lack of nerve conduction velocity (NCV) studies which is the
definite tool for diagnosing neuropathy, as well as aetiology determina-
tion of DPN (e.g., vitamin B12 or folic acid deficiency) further confines
the effectiveness of the present study’s outcome. Also, the study didn’t
account for other potential confounders such as musculo-skeletal con-
ditions of the old age, nutritional deficiencies etc. which might mimic
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Table 5. Socio-demographic factors of the study participants
associated with diabetic peripheral neuropathy according to the
Michigan Neuropathy Screening Instrument examination ver-
sion-bivariate analysis (n=67).
                                                        N.                 %            P-value 
Gender                                                                                                            0.003
Males                                                            42                    42.4
Females                                                        25                    22.9
Cigarette smoking                                                                                      <0.0001
Smokers                                                       26                    68.4
Non-smokers                                               41                    24.1
Alcoholic status                                                                                             0.039
Alcoholics                                                    20                    64.5
Non-alcoholics                                            47                    26.6
Age                                                                                                                   0.039
30-39 years                                                    0                       0
40-49 years                                                   15                    29.4
50-59 years                                                   14                    32.6
60 years and older                                      38                    38.0
Fasting blood glucose                                                                                  0.001
More than 120 mg/dL                                 21                    55.3
Less than 120 mg/dL                                   7                     17.5
Marital status                                                                                                 0.543
Married                                                         59                    31.6
Unmarried/divorced/widowed                  8                     38.1
Duration of diabetes mellitus                                                                    0.277
More than 10 years                                    43                    29.9
Less than 10 years                                      24                    37.5
Table 6. Unadjusted and adjusted odds ratios (ORs) for determinants associated with Diabetic Peripheral Neuropathy according to
Michigan Neuropathy Screening Instrument examination version.
Determinant                                        Unadjusted ORs                              Adjusted ORs
                                                                                    OR (CI)                    P-value                                        OR (CI)                    P-value
Male sex                                                                                           2.5 (1.4-4.5)                           0.003                                                    1.5 (0.7-2.9)                           0.215
Smokers                                                                                         6.8 (3.1-14.7)                       <0.0001                                                5.9 (1.9-17.3)                         0.001
Alcoholics                                                                                       5.0 (2.2-11.3)                       <0.0001                                                 1.5 (0.5-4.8)                           0.440
Age >40 years                                                                                 1.4 (1.0-2.0)                           0.017                                                    2.7 (1.2-5.8)                           0.011
Fasting blood glucose >120 g/dL                                              5.8 (2.0-16.4)                          0.001                                                    5.6 (0.6-9.9)                           0.430
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the symptoms of DPN. Nonetheless, the present study has some
strength in terms of use of a valid and easy to use scale on an adequate
sample of population with reasonably good response rate among them. 
Conclusions
Peripheral neuropathy is a permanent, irreversible, debilitating but
preventable micro-vascular complication of uncontrolled diabetes mel-
litus, which if sets in a patient will have a significant devastating effect
on his/her quality of life. From the results of this study we would like to
conclude that the burden of DPN is high among diabetics, with an espe-
cially higher prevalence among males, smokers and people with long
standing diabetes mellitus. Interventions in the form of early detection
through routine screening and regular follow up examinations would
go a long way in reducing the burden of disability among diabetics and
improve their quality of life significantly. 
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